Mutya Harsch
CIK 1727809 · CHIEF LEGAL OFFICER AND GC · last filed 2026-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$79.1K
Companies
4
Total Filings
50
Lifetime Open-Market Net
$14.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | CHIEF LEGAL OFFICER AND GC | 121,898 | $0.65 | $79.1K | $25.0K | 32 | 2026-04-02 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Director | — | $1.10 | — | $0 | 3 | 2023-06-08 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Chief Legal Officer and GC | 318,887 | — | — | $0 | 5 | 2020-07-02 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | CLO and General Counsel | 98,232 | — | — | -$10.9K | 9 | 2020-03-03 |
Recent Filings · Page 5 of 5
50 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-11 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | +58,191 | $0 | EDGAR |
| 2020-03-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +1,761 | $4.7K | EDGAR |
| 2020-02-24 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +41,299 | $0 | EDGAR |
| 2020-01-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Tax (F) | −618 | -$2.0K | EDGAR |
| 2019-12-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +4,284 | $9.2K | EDGAR |
| 2019-10-02 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Tax (F) | −463 | -$1.4K | EDGAR |
| 2019-07-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Sell (S) | −639 | -$1.5K | EDGAR |
| 2019-04-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Sell (S) | −2,519 | -$9.4K | EDGAR |
| 2019-01-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +30,127 | $0 | EDGAR |
| 2018-02-28 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
Showing 41–50 of 50
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.